Sarepta Therapeutics Income Statement - Quarterly (NASDAQ:SRPT)

Add to My Stocks
$30.38 $1.7 (5.93%) SRPT stock closing price Feb 22, 2017 (Closing)

Financial statements provide us with a way to gain insights and undertake the fundamental analysis of a company. Checking Sarepta Therapeutics stock price alone is not sufficient. In the income statement, an investor can check for important parameters like the topline, the bottomline, the EPS basic, dividends etc. The income statement is generated for a specific period of time. Investors typically check year over year or quarter over quarter revenue growth. One also needs to look at Sarepta Therapeutics assets, operating expenses and Sarepta Therapeutics free cash flow. Our Sarepta Therapeutics revenue chart gives a clear visual representation of how the topline growth has been. Investors often invest in only those companies where the revenue is growing at a steady rate.

  • Bottom line: Most businesses like Sarepta Therapeutics try to improve their bottom line by growing their topline and by increasing their operating efficiency. A healthy bottom line growth implies a good investment.
  • View details of revenue and profits for Sarepta Therapeutics for latest & last 40 quarters.

    show more
    Annual
    Quarterly
    View Previous Quarters
    View Next Quarters
    Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
    Sarepta Therapeutics Net Sales or Revenues
    ---1.25M---0.03M1.06M2.58M
    Cost Of Goods Sold (COGS)----------
    Sarepta Therapeutics Gross Profit
    ---1.25M---0.04M1.05M2.58M
    Research & Development Expense34.34M-38.82M41.38M36.67M29.18M39.16M30.84M21.85M20.64M
    Selling General & Admin Expense22.18M-20.87M24.34M15.09M12.92M22.69M13.92M12.88M12.21M
    Income Before Depreciation Depletion Amortization-56.53M--59.7M-64.46M-51.76M-42.1M-61.86M-44.72M-33.67M-30.27M
    Depreciation Depletion Amortization----------
    Non Operating Income-0.2M--0.06M-0.23M-0.17M0.25M0.3M0.31M4.44M-3.6M
    Interest Expense----------
    Sarepta Therapeutics Pretax Income
    -56.74M--59.77M-64.7M-51.93M-41.85M-61.55M-44.42M-29.22M-33.87M
    Provision for Income Taxes----------
    Minority Interest----------
    Investment Gains Losses----------
    Other Income----------
    Income Before Extraordinaries & Disc Operations-56.74M-62.3M-59.77M-64.68M-51.94M-41.85M-61.56M-44.42M-29.23M-33.87M
    Extraordinary Items & Discontinued Operations----------
    Sarepta Therapeutics Net Income (Profit/Loss)
    -56.74M-62.3M-59.77M-64.68M-51.94M-41.85M-61.56M-44.42M-29.23M-33.87M
    Average Shares used to compute Diluted EPS48.25M46.16M45.7M44.88M41.57M41.36M41.32M41.3M41.07M39.86M
    Average Shares used to compute Basic EPS48.25M46.16M45.7M44.88M41.57M41.36M41.32M41.3M41.07M39.86M
    Income Before Nonrecurring Items-52.8M-61.68M-59.77M-64.68M-51.94M-41.85M-61.56M-44.41M-33.48M-33.87M
    Income from Nonrecurring Items-3.94M-0.63M------4.26M-
    Sarepta Therapeutics Earnings Per Share Basic Net
    -1.18-1.35-1.31-1.44-1.25-1.01-1.49-1.08-0.71-0.85
    Sarepta Therapeutics Earnings Per Share Diluted Net
    -1.18-1.35-1.31-1.44-1.25-1.01-1.49-1.08-0.71-0.85
    EPS Diluted Before Nonrecurring Items-1.10-1.34-1.31-1.44-1.25-1.01-1.49-1.08-0.81-0.85
    Preferred Dividends Acc Pd----------
    Dividends Common----------
    Dividend Per Share Common----------
    All figures in USD. M: Millions of USD, B: Billions of USD.
    View Previous Quarters
    View Next Quarters
    Get Income statement for another ticker

    1:11
    SRPT
    The income statement is also called statement of revenue and expense. The financials along with Sarepta Therapeutics historical stock prices provides a lot of details about the firm. .